Share Data


Common Shares Issued and Outstanding
             
(number of shares)   For the period ended
February 7, 2008
  2007   2006   2005  

Beginning of period
    83,054,528     82,561,272     82,364,899     84,268,293  
Issued upon exercise of options     43,445     493,256     196,373     695,157  
Repurchased                 (2,598,551 )
End of period     83,097,973     83,054,528     82,561,272     82,364,899  

Employee Incentive Stock Options
             
(number of shares)   For the period ended
February 7, 2008
  2007   2006   2005  

Beginning of period
    4,054,567     5,478,697     5,107,611     5,849,131  
Granted     223,550     174,100     1,007,259     532,750  
Exercised     (56,502 )   (1,547,696 )   (567,795 )   (1,257,857 )
Cancelled     (4,138 )   (50,534 )   (68,378 )   (16,413 )
End of period     4,217,477     4,054,567     5,478,697     5,107,611  

DISCLOSURE CONTROLS AND PROCEDURES

NOVA Chemicals’ management, with the participation of the Chief Executive Officer (CEO) and Chief Financial Officer (CFO), has evaluated the effectiveness, as at Dec. 31, 2007, of NOVA Chemicals’ disclosure controls and procedures (as defined in Rules 13a-15e and 15d-15e under the United States Securities Exchange Act of 1934) and has concluded that such disclosure controls and procedures are effective.

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

There have been no changes in NOVA Chemicals’ internal control over financial reporting during the year ended Dec. 31, 2007, that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting. Management has determined that no material change in internal control over financial reporting has occurred as a result of the implementation of the INEOS NOVA joint venture.

ADDITIONAL INFORMATION

Additional information relating to NOVA Chemicals, including the Annual Information Form, is filed with Canadian securities administrators and can be accessed through the System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com. This same information is filed with the U.S. Securities and Exchange Commission and can be accessed via its Electronic Data Gathering, Analysis and Retrieval System (EDGAR) at www.sec.gov/edgar.shtml.